You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC

Advancing Care for Neuro-Oncology: The Most Recent Updates for Your Practice

  • Authors: David Reardon, MD
  • CME / ABIM MOC Released: 1/18/2022
  • Valid for credit through: 1/18/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for oncologists, neurologists, surgeons, pediatricians, and other members of the healthcare team involved in the care of patients with neuro-oncologic conditions.

The goal of this activity is to improve clinicians’ understanding of the latest advances in neuro-oncologic conditions, with a focus on glioblastoma and low-grade gliomas.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Key clinical trial data evaluating treatments for neuro-oncologic conditions
  • Demonstrate greater confidence in their ability to
    • Incorporate emerging clinical trial data into the treatment paradigm for patients with neuro-oncologic conditions


Disclosures

All of the relevant financial relationships listed for these individuals have been mitigated.


Faculty

  • David Reardon, MD

    Professor of Medicine
    Harvard Medical School
    Clinical Director, Center for Neuro-Oncology
    Dana-Farber Cancer Institute
    Boston, Massachusetts

    Disclosures

    Disclosure: David Reardon, MD, has the following relevant financial relationships:
    Independent contractor for: AbbVie; Advantagene; Agenus; Agios; Amgen; Bayer; Boston Biomedical; Boehringer Ingelheim; Bristol Myers Squibb; Celldex; Deciphera; DelMar; EMD Serono; Genenta; Genentech/Roche; Imvax; Inovio; Kintara; Kiyatec; Medicenna Biopharma, Inc.; Merck; Merck KGaA; Monteris; Neuvogen; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline; Sumitono Dainippon Pharma Oncology, Inc.; Taiho Oncology, Inc. 
    Grants for clinical research from: Acerta Pharmaceuticals; Agenus; Celldex; EMD Serono; Incyte; Inovio; Omniox; Tragara 
    Advisor or consultant for: AbbVie; Advantagene; Agenus; Agios; Amgen; Bayer; Boston Biomedical; Boehringer Ingelheim; Bristol Myers Squibb; Celldex; Deciphera; DelMar; EMD Serono; Genenta; Genentech/Roche; Imvax; Inovio; Kintara; Kiyatec; Medicenna Biopharma, Inc.; Merck; Merck KGaA; Monteris; Neuvogen; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline; Sumitono Dainippon Pharma Oncology, Inc.; Taiho Oncology, Inc. 

Editor

  • Charlotte Warren

    Senior Director, Content Development, Medscape, LLC

    Disclosures

    Disclosure: Charlotte Warren, has disclosed no relevant financial relationships.

  • Tristin Abair, PhD

    Senior Medical Writer, Medscape, LLC

    Disclosures

    Disclosure: Tristin Abair, PhD, has disclosed no relevant financial relationships.

CME Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Amanda Jett, PharmD, BCACP, has disclosed no relevant financial relationships.

All other faculty, planners and non-faculty contributors involved in the planning, development, editing, and review of the content have no relevant financial relationships with ineligible companies.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Advancing Care for Neuro-Oncology: The Most Recent Updates for Your Practice

Authors: David Reardon, MDFaculty and Disclosures

CME / ABIM MOC Released: 1/18/2022

Valid for credit through: 1/18/2023

processing....

Assessment Survey

Before you begin, please take this brief survey.